Open Trials

At Shenandoah Oncology, research is an integral part of our comprehensive efforts to provide cancer patients in our community with access to the latest and most advanced therapies and treatment options.  With collaborations with Sarah Cannon Research Institute (SCRI) and VCU Massey Cancer Center, we are pleased to share this list of clinical trials currently enrolling at our practice.

BREAST CANCER - ADJUVANT

USOR 22-326: Phase 3, open-label, randomized study to assess the efficacy and safety of camizestrant (AZD9833, a next-generation, oral selective estrogen receptor degrader) vs standard endocrine therapy (aromatase inhibitor or tamoxifen) as adjuvant treatment for patients with ER+/HER2- early breast cancer and an intermediate-high or high risk of recurrence who have completed definitive locoreginal treatment and have no evidence of disease (CAMBRIA-2). Click here to learn more

SWOG S2010: Phase 3, randomized trial comparing active symptom monitoring (AMS) + Pt education vs Pt education alone to Improve persistence w/ ET in young women with stage I-III breast cancer Click here to learn more

WF-2202: SHINE- Optimizing Psychosocial Intervention for Breast Cancer-related Sexual Morbidity: The Sexual Health and Intimacy Education Trial. Click here to learn more

LUNG

USOR 22-285: Molecularly informed lung cancer treatment in a community cancer network: A longitudinal prospective real-world evidence study (MYLUNG Consortium Part 3 Observations Study). Click here to learn more

USOR 23-235: Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer. Click here to learn more

PREVENTION

URCC 19-185: Multicenter, randomized trial comparing Brief Behavioral Therapy for Cancer Related Insomnia (BBT-CI) vs. Healthy Eating Education Learning (HEAL) for treatment of insomnia. Click here to learn more

SOLID TUMOR

USOR 22-311: Harbinger Health Collection of Blood and Tissue Samples from Cancer and Non-Cancer Subjects for Validation of a Novel Blood-Based Multi-Cancer Screening Test (HH-PRT-0001) Click here to learn more